
New lab space promotes ‘happy collisions’ among scientists
Dedicated space for the Convergent Science Institute in Cancer initiative aims to get biologists, physicists and chemists collaborating on cutting-edge ideas that benefit patients.
Dedicated space for the Convergent Science Institute in Cancer initiative aims to get biologists, physicists and chemists collaborating on cutting-edge ideas that benefit patients.
Tracking the physical activity levels of people receiving chemotherapy can improve their care and even predict emergency room visits, according to USC research.
Sophie Mansfield started out as a high school student in a special program at the Lawrence J. Ellison Institute for Transformative Medicine of USC. Learn how the USC graduate now works equity in cancer care.
The research — co-led by the USC Norris Comprehensive Cancer Center — identified 86 new genetic variations that increase the risk of prostate cancer.
Big data studies in diverse populations will offer new insights into cancer risk and help USC investigators target outreach, screening and prevention efforts.
Tobacco smoking is the leading cause of bladder cancer, but this is the first study to suggest that smoking puts bladder cancer patients at risk after their diagnosis.
A USC study suggests that high-intensity focused ultrasound ablation is an effective alternative to surgery or radiation, with shortened recovery time.
The emeritus professor of pediatrics was influential in the establishment of the cancer center.
USC research has uncovered that commonly used coloring agents like tattoo inks and food dyes can illuminate cancer cells, differentiating them from normal adjacent cells.
The guidelines evaluate existing research and treatment options for clinicians and patients to maximize lymphedema volume-reducing treatment.
Inspired by his father’s fight against non-Hodgkin’s lymphoma, Remo Rohs leads USC’s efforts in studying the molecular nature of cancer.
USC researchers are using AI to fuel more confident diagnosis of renal tumors, as well as more customized treatment for cancer patients and patients infected with COVID-19.
The tool, developed by USC researchers, could help identify patients with the most to gain from a clinical trial as well as guide therapeutic targets.
The renowned oncologist and cancer researcher will join USC in this newly created position in September.
A USC-led team of international scientists found that a one-two punch of a fasting-mimicking diet with hormone therapy may enhance the effects of breast cancer treatment.
A Keck Medicine of USC study found that socioeconomic status plays an important role in access to chemotherapy.
The gift creates and supports the Rosalie and Harold Rae Brown Center for Cancer Drug Discovery, which will focus on accelerating the development of groundbreaking cancer treatments.
Chemical engineers at USC Viterbi have unlocked a fatal vulnerability in many cancer cells: sugar inflexibility.
Computational models developed by USC researchers indicate that keeping tumor cells in competition can lead to more effective cancer treatments.
According to a new USC study, roughly 12% of men of African ancestry carry a variant in their genome that increases their prostate cancer risk twofold.
The current way to make a highly targeted type of drug called “antibody-drug conjugates” is lengthy and inefficient. Scientists at the USC School of Pharmacy have engineered something better.
A USC study found that a combination of a fasting-mimicking diet plus vitamin C delayed tumor progression and even caused disease regression in mice.
The grant of nearly $5 million to USC Stem Cell scientist Min Yu recognizes her innovative work with rare circulating tumor cells.
Ebony Flowers, a postdoctoral fellow at USC Stem Cell, will use the support from the fellowship to further study the role of free radicals in breast cancer.